Our findings reveal a significant upregulation of Sphk1 in peri-hematomal endothelial cells in both human and murine ICH, which was attenuated by Sphk1 inhibition, subsequently reducing hematoma volume, brain edema, and neurological deficits. The gene discussed is SPHK1; the disease is hematoma.